News
J&J vaccine 85% efficacious against severe COVID globally
February 1, 2021
The efficacy against severe disease provided by the Janssen/J&J vaccine held true regardless of age, race/ethnicity, absence or presence of comorbidities, and geography.
News
‘Category 5’ COVID hurricane approaches, expert says
February 1, 2021
The United States has reported 467 cases of the coronavirus variant first identified in the United Kingdom, across 32 states, as well as variants identified in South Africa and Brazil.
News
Newer iPhones disable implanted defibrillators
February 1, 2021
Some newer smartphones are equipped with magnets sufficiently powerful to disable an implanted cardiac defibrillator.
News
Tough pain relief choices in the COVID-19 pandemic
February 1, 2021
The investigators found no evidence of a harmful effect of NSAIDs on COVID-19–related deaths.
News
New updates for Choosing Wisely in hospitalized patients with infection
February 1, 2021
Which new Choosing Wisely recommendations should hospitalists incorporate into their practice to avoid unnecessary testing, reduce harm, and lower cost?
News
Dr. Fauci sees ‘wake-up call’ in emergence of new virus variants
February 1, 2021
“The virus will continue to mutate and will mutate for its own selective advantage,” said Anthony S. Fauci, MD.
News
The COVID-19 virus may prompt the body to attack itself
February 1, 2021
Autoantibodies were more common after COVID – 50% of people hospitalized for their infections had autoantibodies, compared with less than 15% of those who were healthy and uninfected.
News
Ceftolozane-tazobactam found effective in critically ill patients with Pseudomonas aeruginosa infections
January 29, 2021
The primary outcome of the study was to assess the efficacy and toxicity of C/T therapy.
News
Antipsychotic administration fails to treat delirium in hospitalized adults
January 29, 2021
Is there benefit to antipsychotic administration to treat delirium in adult inpatients?
News
COVID-19 may alter gut microbiota
January 29, 2021
Changes in gut microorganisms may contribute to severe disease and long-term symptoms after the virus clears.